HY'BRED International, Inc. (Pinksheets: HYII)

HY'BRED International, Inc. (Pinksheets: HYII), holds a patent-pending design for a horseshoe that addresses the No 1. cause of serious injuries in the equine industry. Such injuries may lead to the horse's untimely death. The HY'BRED horseshoe is easily mounted on the horse using traditional methods. The production process bonds urethane to aluminum to produce a shoe with a built-in shock absorber that relieves stress from the horse's legs. 

If you owned one of these beautiful horses how much would  you  spend to protect your sizeable investment? The HY'BRED horseshoe is the most advanced Aluminum/Rubber horseshoe on the market today. Unsurpassed shock absorption, superior traction and improved protection, combined with the best wear resistance of any synthetic horseshoe makes the HY'BRED the ultimate choice for every horse.

HY'BRED has spent five years in R & D and testing with advice from several of the country’s premier farriers, veterinarians and jockeys to bring to market a high quality therapeutic horse shoe that has multiple world-wide equestrian applications extending from horse racing to mounted police units. A horse with an injured hoof simply cannot function normally. Unfortunately, horse care practices have remained virtually unchanged for more than a century, leading to perpetual problems. With more than a dozen ways that steel shoes are known to damage the feet, legs, and circulatory system of the horse, one of the worst issues is loss of shock absorption.
<<<Spacer>>>

The HY'BRED Horseshoe

<<<Spacer>>>

HY’BRED has developed an innovative composite horseshoe that combines advanced materials and cutting-edge design to incorporate the latest technology to reduce impact and increase shock absorption. The HY'BRED horseshoe is the most advanced Aluminum/Rubber horseshoe on the market today. Unsurpassed shock absorption, superior traction and improved protection, combined with the best wear resistance of any synthetic horseshoe makes the HY'BRED the ultimate choice for every horse.

The HY'BRED horseshoe can be used as a true orthopedic device, designed to allow fluid movement, traction, shock absorption, and as a therapeutic alternative to traditional shoeing methods.
 

The Company has enlisted four of the top industry professionals to aid it in its marketing campaign.  These individuals include Ian McKinlay, the leading authority in hoof lameness, Doyle Blagg, a fourth generation farrier with over 50 years experience, Alan Donell (DVM), U.S. veterinarian for the World Equestrian Games where the US won the gold and Mike Wildenstein, inductee into the Farrier Hall of Fame and Cornell University Professor.  The Company’s team of experts has a combined history of one hundred years of experience.  These industry professionals will represent the Hybred Horseshoe at hoof care summits, farrier conventions and dealer shows throughout the world.  Educating the consumer is the single most important key to the Company’s success.  Having booths manned by the best in the industry, which are Hybred International’s celebrity spokespeople,  gives the consumer the "face to face" communication to help better understand not only the product but hoof related ailments.  Each of the above mentioned experts has endorsed the Hybred Horseshoe.

In testing the validity of the HY'BRED horseshoes' claims, we have been able to affix our shoe to a number of equine concerns. Case studies have been conclusive in their findings that the shoe provides significant benefits to the soundness of the equine athlete. In the design, we recognized the importance of our clients to have the ability to slide a bit before contact, which enables a more natural fluid movement. Once the hoof has ground contact, it was equally important to provide a confident stability which our design offers.

Numerous studies have shown the concussive benefits of a Urethane to ground over the steel/aluminum to ground connection. The HY'BRED horseshoe provides the ability to absorb the loading force; significantly providing substantial shock reduction characteristics. Additionally, the scope of our testing enabled us to work with horses with multiple pathologies include Osteochondrosis (OCD), Splints, Sidebone, Ringbone, Arthritis or Degenerative Joint Disease, Caudal Heel pain and Laminitis. We found that a Farrier could use the HY'BRED horseshoe in place of traditional shoeing for all the concerns.

Breaking News From Hy'bred

HACKENSACK, NJ, Jun 09, 2009 (MARKETWIRE via COMTEX) -- Hy'bred International, Inc. (PINKSHEETS: HYII) is pleased to announce they have contracted World Market Media to launch the company's global social marketing presence. The contract is to begin immediately and is focused on World Market Media's ability to present the company and their products on a global level.

"As demand for products such as Hy'bred's is not just limited to the United States, we felt choosing a partner that is capable of effectively presenting our company and products globally would help stimulate international revenue much faster. As the world becomes more familiar with our products and our ability to help prevent the injury or untimely death of horses, we firmly believe our product will be purchased from every continent," stated C.E.O. Gary Koulatas.

HY'BRED International, Inc. (PINKSHEETS: HYII), a development stage company, holds a patent-pending design for a horseshoe which addresses the No 1. cause of serious injuries in the equine industry. The production process bonds urethane to aluminum to produce a shoe with a built-in shock absorber which relieves stress from the horse's legs. This material wears as long as a steel horseshoe, much longer than rubber, and even longer than the aluminum shoe to which it is bound. This process was designed so that farriers can place them on the horse using traditional tools and shoeing methods, which is a tremendous advantage over other traditional shoe alternatives on the market. Hy'bred International is traded over the OTC markets with the ticker symbol HYII.

VOD Newswire

SOURCE: Hy'bred International, Inc.

Press Release Source: HY'BRED International, Inc.
On Friday June 5, 2009, 4:30 pm EDT

HACKENSACK, NJ--(MARKET WIRE)--Jun 5, 2009 -- HY'BRED International, Inc. (Other OTC:HYII.PK - News), a development stage company, holds a patent-pending design for a horseshoe which addresses the No 1. cause of serious injuries in the equine industry. Such injuries may lead to the horse's untimely death. The HY'BRED horseshoe is easily mounted on the horse using traditional methods. The production process bonds urethane to aluminum to produce a shoe with a built-in shock absorber which relieves stress from the horse's legs.

HY'BRED International, Inc. has confirmed it has entered into an agreement with Anaheim-based Thoro'Bred, Inc., the world's largest aluminum horseshoe manufacturer, to produce these revolutionary shoes. Thoro'Bred, Inc. will manufacture the shoes in their California facility utilizing HY'BRED's patented procedure.

Additionally, Thoro'Bred has agreed to market HY'BRED's product in their own catalogue and in tandem with their products. This additional market exposure introduces HY'BRED's product to virtually every domestic farrier, tack shop, and supply store in the United States.  MORE

Press Release Source: Hybred International, Inc.
On Wednesday December 3, 2008, 8:00 am EST

HACKENSACK, N.J., Dec. 3, 2008 (GLOBE NEWSWIRE) -- Hybred International, Inc. (The Company) (Other OTC:HYII.PK - News), manufacturer of a patent-pending therapeutic horseshoe and in collaboration with Thoro'bred, Inc. of Anaheim, California, is proud to announce that mass production of the HYBRED horseshoe is underway. Hybred International, Inc. is now fully funded to produce the Hybred Horseshoe and bring to market a product that can truly improve a horse's life.

In addition to the grueling research and development work completed by the Company during the last three years, Hybred comes to market with an agreement with Thoro'bred, Inc., the world's largest aluminum horseshoe manufacturer. Under the terms of the agreement, Thoro'bred, Inc will manufacture and market the Hybred Horseshoe through its catalogue, tack shops, farrier and supply stores and marketing materials in the U.S. and abroad. MORE
<<<Spacer>>>

Connect with HYII on Twitter and Facebook

Financial Highlights

Opportunity
It is estimated that there are approximately 9 million horses in the United States.  The average shoeing will last approximately one month, and applying that turnover rate with four horseshoes per horse, the total horseshoe market in the United States is estimated at 432 million shoes per annum.  The overall retail price on average for a pair of horseshoes is approximately $15.00.  Based on the foregoing, the horseshoe industry, exclusive of any labor and tooling, is approximately a $3.2 billion a year industry. There are more than 52 million horses outside the United States, thus representing a potential market opportunity of an additional $18.7 billion.

Company Contacts

HY'BRED International, Inc.
370 West Pleasantview Avenue, Suite 163
Hackensack, NJ 07601
United States

Phone: 201/788-3785
Fax: 973/777-6776
Web Site: http://www.HYBREDhorseshoe.com

---

*** The Bull is Running. ***
There may never be a better time to feature YOUR company
to over 1 MILLION investors.

To learn more about our programs email us directly at info@stockupticks.com

Market Pathways
17595 Harvard Ave., Suite C519 Irvine, CA  92614
949-955-0107

Disclaimer: StockUpTicks.com is a property of Market Pathways Financial Relations Incorporated (MP).  The information, opinions and analysis contained herein are based on sources believed to be reliable but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. Past performance is no guarantee of future results. This report is a paid advertisement and is for information purposes only and should not be used as the basis for any investment decision.  MP has been granted three hundred fifty thousand shares of Hy'bred Int'l Inc. stock without restriction by Golden Key LLC for preparation and distribution of this report and other advertising services. MP intends to sell said shares in the open market as soon as possible and will do so without further notice. This constitutes a conflict of interest as to MP’s ability to remain objective in its communication regarding the subject company. Write or call MP for detailed disclosure as required by Rule 17b of the Securities Act of 1933/1934.  MP is not an investment advisor and this report is not investment advice. This information is neither a solicitation to buy nor an offer to sell securities but is a paid advertisement.  Information contained herein contains forward-looking statements and is subject to significant risks and uncertainties, which will affect the results.  The opinions contained herein reflect our current judgment and are subject to change without notice. MP and/or its affiliates, associates and employees from time to time may have either a long or short position in securities mentioned.  Information contained herein may not be reproduced in whole or in part without the express written consent of Market Pathways Financial Relations Incorporated.